• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

注册随机对照试验:一种方法学视角。

Registry randomised trials: a methodological perspective.

机构信息

UWA Medical School, The University of Western Australia, Perth, Western Australia, Australia.

Biostatistics and Research Design Unit, King Edward Memorial Hospital for Women Perth, Subiaco, Western Australia, Australia.

出版信息

BMJ Open. 2023 Mar 1;13(3):e068057. doi: 10.1136/bmjopen-2022-068057.

DOI:10.1136/bmjopen-2022-068057
PMID:36858472
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC9980340/
Abstract

Registry randomised clinical trials (RRCTs) have the potential to provide pragmatic answers to important clinical questions. RRCTs can be embedded into large population-based registries or smaller single site registries to provide timely answers at a reduced cost compared with traditional randomised controlled trials. RRCTs can take a number of forms in addition to the traditional individual-level randomised trial, including parallel group trials, platform or adaptive trials, cluster randomised trials and cluster randomised stepped-wedge trials. From an implementation perspective, initially it is advantageous to embed RRCT into well-established registries as these have typically already overcome any issues with end point validation and adjudication. With advances in data linkage and data quality, RRCTs can play an important role in answering clinical questions in a pragmatic, cost-effective way.

摘要

注册随机临床试验(RRCTs)有可能为重要的临床问题提供实用的答案。RRCT 可以嵌入到大的基于人群的登记处或较小的单一地点登记处,与传统的随机对照试验相比,以更低的成本提供及时的答案。RRCT 除了传统的个体水平随机试验外,还可以采用多种形式,包括平行组试验、平台或适应性试验、集群随机试验和集群随机阶梯式试验。从实施的角度来看,最初将 RRCT 嵌入到成熟的登记处是有利的,因为这些登记处通常已经解决了终点验证和裁决的任何问题。随着数据链接和数据质量的进步,RRCT 可以在以实用且具有成本效益的方式回答临床问题方面发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e6/9980340/c38e6c979862/bmjopen-2022-068057f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e6/9980340/fdc0e856be0b/bmjopen-2022-068057f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e6/9980340/c38e6c979862/bmjopen-2022-068057f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e6/9980340/fdc0e856be0b/bmjopen-2022-068057f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e6/9980340/c38e6c979862/bmjopen-2022-068057f02.jpg

相似文献

1
Registry randomised trials: a methodological perspective.注册随机对照试验:一种方法学视角。
BMJ Open. 2023 Mar 1;13(3):e068057. doi: 10.1136/bmjopen-2022-068057.
2
Registry-based randomised controlled trials: conduct, advantages and challenges-a systematic review.基于注册的随机对照试验:实施、优势和挑战——系统评价。
Trials. 2024 Jun 11;25(1):375. doi: 10.1186/s13063-024-08209-3.
3
Defining key design elements of registry-based randomised controlled trials: a scoping review.基于注册的随机对照试验的关键设计要素的定义:范围综述。
Trials. 2020 Jun 22;21(1):552. doi: 10.1186/s13063-020-04459-z.
4
"Nothing to lose and the possibility of gaining": a qualitative study on the feasibility and acceptability of registry-based randomised controlled trials among cancer patients and clinicians.“无所得,而有其可能”:基于注册的癌症患者和临床医生的随机对照试验的可行性和可接受性的定性研究。
Trials. 2023 Feb 7;24(1):92. doi: 10.1186/s13063-023-07109-2.
5
Clinical registries data quality attributes to support registry-based randomised controlled trials: A scoping review.临床注册研究数据质量属性支持基于注册的随机对照试验:范围综述。
Contemp Clin Trials. 2022 Aug;119:106843. doi: 10.1016/j.cct.2022.106843. Epub 2022 Jul 2.
6
Paper II: thematic framework analysis of registry-based randomized controlled trials provided insights for designing trial ready registries.论文二:基于注册的随机对照试验的主题框架分析为试验准备注册提供了思路。
J Clin Epidemiol. 2023 Jul;159:330-343. doi: 10.1016/j.jclinepi.2023.04.015. Epub 2023 May 4.
7
Registry-based randomized controlled trials merged the strength of randomized controlled trails and observational studies and give rise to more pragmatic trials.基于注册的随机对照试验结合了随机对照试验和观察性研究的优势,产生了更具实用性的试验。
J Clin Epidemiol. 2018 Jan;93:120-127. doi: 10.1016/j.jclinepi.2017.09.017. Epub 2017 Sep 22.
8
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
9
Paper I: Heterogeneous use of registry data for participant identification and primary outcome ascertainment is found in registry-based randomized controlled trials: A scoping review.文献 I:基于注册的随机对照试验中存在注册数据的参与者识别和主要结局确定的异质性使用:范围综述。
J Clin Epidemiol. 2023 Jul;159:289-299. doi: 10.1016/j.jclinepi.2023.04.016. Epub 2023 May 3.
10
No differences were found between effect estimates from conventional and registry-based randomized controlled trials.常规随机对照试验和基于注册的随机对照试验的效果估计值之间没有差异。
J Clin Epidemiol. 2019 Jan;105:80-91. doi: 10.1016/j.jclinepi.2018.09.011. Epub 2018 Sep 23.

引用本文的文献

1
ENDOCOR: a nationwide consortium of endocarditis teams-initiating a registry for infective endocarditis within the Netherlands Heart Registration.ENDOCOR:一个由心内膜炎治疗团队组成的全国性联盟——在荷兰心脏注册中心内启动一项感染性心内膜炎登记项目。
Neth Heart J. 2025 Sep 3. doi: 10.1007/s12471-025-01979-8.
2
To infinity and beyond: the promise of data-driven 3D printing of hernia mesh - a primer for surgeons.飞向无限,超越想象:数据驱动的疝修补网片3D打印的前景——外科医生入门指南
Hernia. 2025 Sep 1;29(1):270. doi: 10.1007/s10029-025-03434-4.
3
Two-year outcomes of left bundle branch area pacing versus traditional right ventricular pacing in middle-aged adults: a registry-based trial.

本文引用的文献

1
Baseline Characteristics and Representativeness of Participants in the BEST-Fluids Trial: A Randomized Trial of Balanced Crystalloid Solution Versus Saline in Deceased Donor Kidney Transplantation.BEST-液体试验参与者的基线特征及代表性:一项关于平衡晶体溶液与生理盐水在 deceased 供体肾移植中对比的随机试验
Transplant Direct. 2022 Nov 4;8(12):e1399. doi: 10.1097/TXD.0000000000001399. eCollection 2022 Dec.
2
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.巴瑞替尼治疗 COVID-19 住院患者的疗效(RECOVERY 研究):一项随机、对照、开放标签、平台试验及更新的荟萃分析。
Lancet. 2022 Jul 30;400(10349):359-368. doi: 10.1016/S0140-6736(22)01109-6.
3
中年成人左束支区域起搏与传统右心室起搏的两年结局:一项基于注册登记的试验。
Europace. 2025 Aug 4;27(8). doi: 10.1093/europace/euaf181.
4
Nephrology Clinical Trials in Learning Health Systems: The Registry-Based Randomized Clinical Trial.学习型健康系统中的肾脏病临床试验:基于注册库的随机临床试验。
J Am Soc Nephrol. 2024 Sep 1;35(9):1274-1277. doi: 10.1681/ASN.0000000000000448. Epub 2024 Jul 2.
5
Aspirin Versus LMWH for Thromboprophylaxis Following Hip or Knee Arthroplasty-Clinical Implications and Budget Impact.阿司匹林与低分子肝素用于髋或膝关节置换术后血栓预防的临床意义及预算影响
Pharmacol Res Perspect. 2025 Aug;13(4):e70147. doi: 10.1002/prp2.70147.
6
"It's a reasonable gamble"-rural residents' experience participating in cancer clinical trials at a single rural trial unit.“这是一场合理的冒险”——农村居民在一个农村试验单位参与癌症临床试验的经历
Trials. 2025 Feb 25;26(1):67. doi: 10.1186/s13063-025-08731-y.
7
Leptomeningeal metastatic disease: new frontiers and future directions.软脑膜转移瘤:新前沿与未来方向。
Nat Rev Clin Oncol. 2025 Feb;22(2):134-154. doi: 10.1038/s41571-024-00970-3. Epub 2024 Dec 9.
8
Use cases of registry-based randomized controlled trials-A review of the registries' contributions and constraints.基于注册的随机对照试验的应用案例——对注册研究的贡献和限制的回顾。
Clin Transl Sci. 2024 Nov;17(11):e70072. doi: 10.1111/cts.70072.
9
The role of early-phase trials and real-world evidence in drug development.早期临床试验和真实世界证据在药物研发中的作用。
Nat Cardiovasc Res. 2024 Feb;3(2):110-117. doi: 10.1038/s44161-024-00420-4. Epub 2024 Feb 15.
10
Cardiac rehabilitation registries around the globe: current status and future needs.全球心脏康复登记处:现状与未来需求。
Eur J Prev Cardiol. 2024 Nov 18;31(16):e117-e121. doi: 10.1093/eurjpc/zwae182.
Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.加拿大急性缺血性脑卒中静脉内替奈普酶与阿替普酶比较(AcT):一项实用的、多中心、开放标签、与登记系统相关联、随机化、对照、非劣效性试验。
Lancet. 2022 Jul 16;400(10347):161-169. doi: 10.1016/S0140-6736(22)01054-6. Epub 2022 Jun 29.
4
Rapid centralised randomisation in emergency setting trials using a smartphone.在紧急情况下的试验中使用智能手机进行快速集中随机化。
Eur J Pediatr. 2022 Aug;181(8):3207-3210. doi: 10.1007/s00431-022-04475-y. Epub 2022 May 17.
5
Defining key design elements of registry-based randomised controlled trials: a scoping review.基于注册的随机对照试验的关键设计要素的定义:范围综述。
Trials. 2020 Jun 22;21(1):552. doi: 10.1186/s13063-020-04459-z.
6
Towards a national perioperative clinical quality registry: The diagnostic accuracy of administrative data in identifying major postoperative complications.迈向全国围手术期临床质量登记系统:行政数据在识别术后主要并发症方面的诊断准确性。
Anaesth Intensive Care. 2020 May;48(3):203-212. doi: 10.1177/0310057X20905606. Epub 2020 Apr 28.
7
Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.质子泵抑制剂与组胺 2 受体拮抗剂预防应激性溃疡对接受有创机械通气的 ICU 患者院内死亡率的影响:PEPTIC 随机临床试验。
JAMA. 2020 Feb 18;323(7):616-626. doi: 10.1001/jama.2019.22190.
8
Evaluation of the impact of the GRACE risk score on the management and outcome of patients hospitalised with non-ST elevation acute coronary syndrome in the UK: protocol of the UKGRIS cluster-randomised registry-based trial.评价 GRACE 风险评分对英国非 ST 段抬高型急性冠状动脉综合征住院患者管理和结局的影响:英国 GRIS 基于群组随机注册研究的方案。
BMJ Open. 2019 Sep 5;9(9):e032165. doi: 10.1136/bmjopen-2019-032165.
9
Patient Registries: An Underused Resource for Medicines Evaluation : Operational proposals for increasing the use of patient registries in regulatory assessments.患者登记处:药物评估中未充分利用的资源:提高监管评估中患者登记处使用的操作性建议。
Drug Saf. 2019 Nov;42(11):1343-1351. doi: 10.1007/s40264-019-00848-9.
10
Commentary: On the levels of patient selection in registry-based randomized controlled trials.评论:基于注册登记的随机对照试验中的患者选择水平
Trials. 2019 Feb 4;20(1):100. doi: 10.1186/s13063-019-3214-x.